ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Long Term Follow-Up"
Episode Synopsis
Several recent large trials just released long term follow-up results on overall survival. We look at what how treatment principles may change based on these mature data.
ECHELON-1 - Hodgkin's (A+AVD vs. ABVD)
POLO - Pancreatic (olaparib maintenance vs. placebo)
Keynote 355 - mTNBC (pembrolizumab + chemo vs. chemo)
APHinity - adjuvant HER+ breast (pertuzumab/trastuzumab vs. trastuzumab)
E1912 - CLL (ibrutinib/rituximab vs. FCR)
ECHELON-1 - Hodgkin's (A+AVD vs. ABVD)
POLO - Pancreatic (olaparib maintenance vs. placebo)
Keynote 355 - mTNBC (pembrolizumab + chemo vs. chemo)
APHinity - adjuvant HER+ breast (pertuzumab/trastuzumab vs. trastuzumab)
E1912 - CLL (ibrutinib/rituximab vs. FCR)
More episodes of the podcast OncoPharm
Bladder Cancer Updates & SC Amivantamab
18/12/2025
ASH 2025
11/12/2025
DPYD Deficiency Testing
04/12/2025
Cornucopia of Autumn Updates
26/11/2025
PGYNone: Dandelion Effect
20/11/2025
PGY1 Pathway: Road Trip!
13/11/2025
PGY2 Pathway: A Planned City
06/11/2025
Tale from the Crypt: Belantamab Mafodotin
30/10/2025
ESMO 2025
23/10/2025
IL-2
16/10/2025
In God we trust